SN vs. HLN, SGE, WHR, ANP, CLX, TPX, PNPL, LEG, ULVR, and NIOX
Should you be buying Smith & Nephew stock or one of its competitors? The main competitors of Smith & Nephew include Haleon (HLN), The Sage Group (SGE), Warehouse REIT (WHR), Anpario (ANP), Calnex Solutions (CLX), TPXimpact (TPX), Pineapple Power (PNPL), Legendary Investments (LEG), Unilever (ULVR), and NIOX Group (NIOX).
Smith & Nephew vs. Its Competitors
Haleon (LON:HLN) and Smith & Nephew (LON:SN) are both large-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their institutional ownership, analyst recommendations, dividends, profitability, media sentiment, risk, earnings and valuation.
Haleon presently has a consensus price target of GBX 435, indicating a potential upside of 21.54%. Smith & Nephew has a consensus price target of GBX 1,379.33, indicating a potential upside of 1.95%. Given Haleon's higher probable upside, analysts clearly believe Haleon is more favorable than Smith & Nephew.
In the previous week, Smith & Nephew had 2 more articles in the media than Haleon. MarketBeat recorded 6 mentions for Smith & Nephew and 4 mentions for Haleon. Smith & Nephew's average media sentiment score of 0.59 beat Haleon's score of -0.17 indicating that Smith & Nephew is being referred to more favorably in the news media.
Haleon pays an annual dividend of GBX 6 per share and has a dividend yield of 1.7%. Smith & Nephew pays an annual dividend of GBX 29 per share and has a dividend yield of 2.1%. Haleon pays out 50.5% of its earnings in the form of a dividend. Smith & Nephew pays out 104.4% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future.
43.9% of Haleon shares are held by institutional investors. Comparatively, 62.2% of Smith & Nephew shares are held by institutional investors. 10.7% of Haleon shares are held by insiders. Comparatively, 0.2% of Smith & Nephew shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.
Haleon has a beta of 0.19, indicating that its stock price is 81% less volatile than the S&P 500. Comparatively, Smith & Nephew has a beta of 0.62, indicating that its stock price is 38% less volatile than the S&P 500.
Haleon has a net margin of 9.66% compared to Smith & Nephew's net margin of 5.41%. Haleon's return on equity of 6.54% beat Smith & Nephew's return on equity.
Haleon has higher revenue and earnings than Smith & Nephew. Haleon is trading at a lower price-to-earnings ratio than Smith & Nephew, indicating that it is currently the more affordable of the two stocks.
Summary
Smith & Nephew beats Haleon on 9 of the 17 factors compared between the two stocks.
Get Smith & Nephew News Delivered to You Automatically
Sign up to receive the latest news and ratings for SN and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding SN and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip ChartMedia Sentiment Over Time
This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart
Smith & Nephew Competitors List
Related Companies and Tools
This page (LON:SN) was last updated on 8/15/2025 by MarketBeat.com Staff